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ABSTRACT 
 
Protein-protein interactions (PPIs) are a key regulatory mechanism in 
coordinating a multitude of processes vital to normal cellular function.  There exist a 
number of wet-lab small-scale and high-throughput methods for accurately identifying 
PPIs; however, despite their accuracy, these methods are expensive both in terms of time 
and finances.  Complementing experimental methods with computational predictions 
increases the effectiveness of wet-lab small scale methodologies in identifying high 
quality protein interaction networks.  Computational predictions are made by applying 
bioinformatics and machine-learning algorithms to large-scale training sets obtained from 
wet-lab experiments, or by extracting information on PPIs from high volumes of 
published data that do not directly identify protein interactions but are nonetheless 
correlated with them.  A disadvantage of computational predictions is their high degree of 
inaccuracy, namely too many false positives and false negatives.  To improve the 
accuracy of computational predictions, it is important to consider interactions that are 
likely to occur in vivo under certain biological conditions, termed “context”.  One 
technique for improving prediction accuracy is analyzing data obtained via different types 
of experiments that consider different features of the co-occurring proteins, such as co-
localization, co-expression, correlated mutations, or semantic similarity.  These 
experimental sources and their resulting data are called “sources of evidence”.  
Integrating data from multiple independent supporting evidence sources improves 
prediction accuracy.   
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In this work, I used text mining of PubMed abstracts as an evidence source for 
protein interactions.  I hypothesized that proteins whose names are frequently mentioned 
in the same abstract are more likely to interact in vivo compared to randomly chosen 
proteins.  A comparison of three text mining techniques – gene name co-occurrence, 
MeSH term indexing, and co-occurrence with a controlled vocabulary – shows that co-
occurrence with a controlled vocabulary yields the highest precision and recall.   I 
concluded that gene name co-occurrence with a controlled vocabulary can, therefore, be 
used as a novel evidence source for prediction of WW domain-mediated PPIs. 
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CHAPTER 1.  INTRODUCTION 
1.1 – Protein-protein interactions in signaling networks 
 
In the post-genomic era, genes and their products are no longer studied only as 
individual entities but in the context of larger functional interaction networks within the 
cell.  It has become increasingly evident that over 80% of gene products do not function 
in isolation, but form part of a coordinated cell regulatory network (Berggard T et al. 
2007).  An example of a cellular regulatory network is the signal transduction process 
[Fig. 1.1.1], where external stimulation events are converted into intracellular response 
via a series of protein interactions within the cell (Wilks and Harpur 1996).  Extracellular 
signaling molecules, termed ligands, bind to specific receptor proteins on the cell’s 
surface, initiating a physical and/or chemical reaction that is propagated within the cell by 
interacting proteins.  Proteins involved in the signal transmission process form signaling 
pathways and these pathways in turn, assemble into complex networks that control 
cellular function (Pawson and Nash 2000).  Misregulation in signaling networks has been 
observed in diseases such as cancer, muscular dystrophy, Alzheimer’s, and Huntington’s 
disease (Gonzalez M.W.;, Kann, M.G. 2012).  Increased knowledge of protein 
interactions in signaling networks will lead to greater insight into the nature of those 
diseases and to therapeutic advances.  
 
Protein interactions may be direct (physical), where two proteins directly bind to 
each other, or indirect (functional), where no direct contact takes place between the 
interacting partners.  This work focuses on direct physical PPIs.   
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An external stimulator binds to TGF-beta receptors on the surface on the cell, 
initiating a series of interaction events that are propagated within the cell to invoke 
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1.2 – Peptide Recognition Modules 
 
Many protein interactions depend on the activity of peptide recognition modules 
(PRMs).  PRMs are globular protein domains that mediate interactions by binding to 
specific, short, linear regions of other proteins (Sidhu et al. 2014).   Well-known 
examples of PRMs are SH2 and SH3 (Src homology 2 and 3) (Musacchio et al. 1992, 
Mayer et al. 2001, Pawson et al 2001), PDZ (Postsynaptic Density 95 (PSD-95); discs 
large (DLG) and zonula occludens-1 (ZO-1)) (Kennedy 1995, Doyle et al. 1996, Kim et 
al. 2004, Tonikian et al. 2008), PTB (phosphotyrosine-binding) (Zhou et al. 1995), and 
WW (named after the presence of two conserved tryptophan residues, abbreviated as 
‘W’) (Bork and Sudol 1994, Sudol M 1996) domain family members.  Each of these 
domains folds into well-characterized structures typical of that domain and recognizes 
specific peptide motifs (Pawson 2006), [Fig. 1.2.1-1.2.4].  For instance, the WW domain 
is a 38 amino acid-long domain, which contains two conserved tryptophan residues and 
binds proline-rich motifs (Nguyen et al. 1998, Wintjens et al. 2001).  SH2 and PTB 
domains bind to phosphorylated tyrosine residues, while SH3 and WW domains 
recognize proline-rich peptides (Zhou et al. 1995, Kim and Sheng 2004, Pawson 2006).  
Members of these PRM families are involved in a variety of regulatory cellular processes 
(Pawson 2003), and mutations in them lead to misregulated pathways important in 
diseases such as cancer, Alzheimer’s and Huntington’s disease (Pawson 2000). 	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Figure 1.2.1: SH2 Domain 
 
 





SH2 domains contain a central anti-parallel beta-sheet (green) surrounded by two 
alpha-helices (blue).  They bind phosphotyrosine (pY) peptides and are found in a 
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Figure 1.2.2: SH3 Domain 
	  
A Sem5 C-terminal SH3 (Src homology 3) domain complexed to the mSos-derived 





The SH3 domain contains five anti-parallel beta strands (green).  The binding site 
(orange) forms a hydrophobic patch that contains a cluster of conserved aromatic 
residues and is surrounded by two charged and variable loops.  
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Figure 1.2.3: PDZ Domain 
 	  





PDZ domains are composed of approximately 80-90 amino acid (AA) residues and 
contain two alpha-helices (blue) and 5-6 beta strands (green).  The binding site is a 
hydrophobic cleft that binds the peptide’s carboxylate group. 	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Figure 1.2.4: PTB Domain 
 
 




PTB (phospho-tyrosine binding) domain is composed of approximately 100-150 AA 
residues and binds phosphorylated proline-rich motifs (NPXpY).  It contains two 
alpha-helices (blue) and 6 beta sheets (green). 
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1.3 – WW Domains 	  
The WW domain (also known as WWP), described by Bork and Sudol in 1996, is 
a protein domain with two highly conserved tryptophan (‘W’) residues (Bork and Sudol 
1994, Sudol 1996), [Fig. 1.3.1].  The WW domain recognizes and binds to proline-rich 
motifs (Sudol 1996, Pawson and Nash 2003, Ingham et al. 2005).  It is composed of 
approximately 38 amino acid residues and folded into a three-stranded beta-sheet 
structure (Sudol 1996).  Proteins containing this domain are involved in signal 
transduction in pathways such as the Hippo tumour suppressor pathway (Salah and 
Aqeilan 2011, Yu and Guan 2013), and mutations in the domain lead to misregulations 
that have been implicated in diseases such as cancer in mammals (Kodaka and Hata 
2015).  For this reason, the WW domain has been of overlapping interest in the Pawson 
and Bader laboratories; however, extensive research has not been done on them as much 
as on SH2 and SH3 domains.  For these reasons, my thesis focuses on the WW domain. 	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Figure 1.3.1: WW Domain  
 




The WW domain is a 38-AA unit that folds into a 3-stranded beta sheet structure 
and binds proline-rich motifs.  The name ‘WW’ illustrates that the domain contains 
two conserved tryptophan (Trp or ‘W’) residues within its consensus sequence. 
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1.4 – Experimental PPI identification 	  
 
Cellular protein interactions can be identified using several experimental 
techniques.   These techniques include tandem affinity purification (TAP) (Puig et al. 
2001), yeast two-hybrid (Y2H) (Fields and Song 1989, Ito et al. 2001, Walhout and Vidal 
2001, Brückner et al. 2009), co-immunoprecipitation (Co-IP) (Hall 2004, Isono and 
Schwechheimer 2010), peptide arrays (Wu et al. 2007, Katz et al. 2011, Amartely et al. 
2014) or phage display (Kay and Castagnoli 2003, Kokoszka and Kay 2015).   
 
The yeast-two hybrid (Y2H) method (Fields and Song 1989) detects PPIs based 
on the assembly of a transcription factor (TF) and the subsequent activation of selected 
“reporter” genes (Auerbach D, Stagljar I 2005).  A “bait” and a “prey” protein hybrids are 
prepared in yeast.  The “bait” is fused to the reporter gene’s TF’s DNA-binding domain 
(DBD), while the “prey” is fused to the TF’s activation domain (AD).  If the bait and prey 
interact when expressed in a yeast cell that contains a specific “reporter gene”, the 
interaction brings the AD and DBD into close proximity, resulting in a functional TF, 
which, in turn triggers the expression of the reporter gene [Fig. 1.4.1].  Hence, the 
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Figure 1.4.1: Yeast Two-Hybrid (Y2H) PPI detection method 
 
The	  Yeast	  Two-­‐Hybrid	  (Y2H)	  PPI	  detection	  method.	  	  A)	  A	  “bait”	  is	  prepared,	  by	  fusing	   the	   target	   protein	   (P1)	   to	   the	   DBD	   of	   the	   TF.	   	   B)	   A	   “prey”	   is	   prepared,	   by	  fusing	   a	   potential	   binding	  partner	   (P2)	   to	   the	  AD	  of	   the	  TF.	   	   C)	  Bait	   and	  prey	   are	  placed	   inside	   a	   yeast	   cell	   that	   contains	   a	   reporter	   gene.	   	   D)	   Proteins	   P1	   and	   P2	  interact,	  creating	  a	  functional	  TF,	  which	  activates	  transcription	  of	  the	  reporter	  gene.	  	  (Photo	  from	  www.technologyinscience.blogspot.com)	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Co-immunoprecipitation (Co-IP) is an extension of the immunoprecipitation (IP) 
protocol, commonly used for protein detection.  IP targets the protein in question 
(antigen) with an antibody that the protein has a known affinity for and pulls down 
(precipitates) the antigen-antibody complex using an immobilizing agent, such as an Ab-
binding protein, on a beaded surface.   Proteins not precipitated on the beads are washed 
away, and the protein in question is detected using gel electrophoresis followed by 
Western blot.  The Co-IP technique pulls down the bait protein along with its interacting 
partners and, for example, uses mass spectrometry to identify the bait protein.  (Thermo 
Fisher Scientific Inc. 2015) [Fig. 1.4.2].  In the Tandem Affinity Purification (TAP) 
technique, the TAP tag is used instead of direct antibodies to label and later detect the 
bait proteins.  Usually, the bait and prey are then identified by mass spectrometry. (Puig 
et al. 2001) 
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Figure 1.4.2: Co-immunoprecipitation (Co-IP) PPI detection method.   
 
  
Co-IP schema.  A) Interacting proteins in vivo.  B) Proteins in question are extracted 
from the cell and placed in vitro in an extract of low-salt buffer with enzymatic shearing 
to protect the protein complexes C) Antibody with known affinity to one of the 
interacting proteins (bait) is added in vitro D) Antibody binding beads are added E) 
Solution is washed, and proteins in question are immunoprecipitated on the beads F) 
Proteins of interest are collected G) A Western blot is performed to analyze the 
immunoprecipitated PPI using an Antibody against the bait’s interactor 
 
Picture taken from http://www.activemotif.com/images/products/coip_flowchart_big.jpg   
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1.5 – Computational PPI Predictions 
 
1.5.1 – The need for computational predictions 
Despite their accuracy, experimental methods for PPI identification remain costly 
and time-consuming.  Y2H and affinity-based techniques have shown 40%-80% false 
negative rate and around 12% false positive rate, resulting in only partially complete 
interactome maps (Venkatesan et al. 2009).  Moreover, large-scale results for thousands 
of samples often do not answer specific questions related to a particular protein (Leser 
and Hakenberg 2005).  The Y2H method, for instance, cannot reveal interactions between 
more than two proteins (Berggård et al. 2007).  Complementing wet-lab procedures with 
computational predictions can increase the financial and temporal effectiveness of wet-
lab methodologies in identifying high quality protein interaction networks.  
 
1.5.2 – PPI prediction methods 
 
Computational predictions are made by applying bioinformatics and machine-
learning algorithms to training sets obtained from large-scale experiments, such as 
peptide arrays or phage display.  Alternatively, prediction algorithms may extract 
information on protein-protein interactions from high-volume collections of published 
data that do not directly identify protein interactions, but nonetheless are correlated with 
protein interactions.  A simple method for predicting PRM-dependent protein interactions 
involves position-weight matrices or position-specific scoring matrices (PWMs or 
PSSMs) (Sinha 2006, Kerpedjiev et al. 2014).  In this case, PWMs capture the probability 
of an amino acid residue to occur at a specific position in a peptide that is predicted to 
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bind to a PRM, which can be visualized as a sequence logo [Fig. 1.5.1].  Other 
computational PPI prediction methods include high-throughput sequence-based 
approaches (Chen and Jeong 2009, Liu et al. 2012, You et al. 2014), structure-based 
approaches (Hosur 2012), function-based approaches (Schlicker et al. 2006, Wang et al. 
2007), chromosome proximity (Vijaykumar and Vishal 2013), gene clustering (Lee and 
Sonnhammer 2003), in-silico two-hybrid, phylogenetic tree, phylogenetic profile, and 
gene expression-based approaches (Rao et al. 2014).  
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Figure 1.5.1: Position-weight matrix and sequence logo 
 
 
 Saurabh	   Sinha:	   “Counting	   position	  weight	  matrices	   in	   a	   sequence	   &	   an	   application	   to	  




	  	   17	  
1.7 – The downside of computational predictions 
	  
 Predictions made in silico contain many false positives, as bioinformatics methods 
such as PWMs do not take into account the biological context that would make these 
interactions possible in vivo.  Even though computational methods can identify the 
potential of proteins to interact, in reality conditions must be met within the cell in order 
to enable interactions.  These conditions are termed biological context.  Examples of 
biological context include co-localization (presence in the same location in the cell within 
reasonable proximity of each other), co-expression (presence in the cell at the same time), 
favorable conformation that permits interaction, or accessibility of interacting regions on 
the proteins’ surfaces.  Hence, a solid computational prediction model considers ‘real’ 
interactions, i.e. possible under certain biological conditions (“cellular context”), to 
reduce the number of false positives and discard predicted interactions that are not likely 
to occur in vivo.   
	  
 
1.6 – Sources of evidence for PPIs 
 
Prediction datasets in a specific biological context are termed “sources of evidence” (or 
“evidence sources”) for protein interactions.  Co-localization, co-expression, surface 
accessibility, pathway co-occurrence, correlated mutations, and evolutionary 
conservation are all examples of evidence sources. Integrating data from multiple 
independent supporting evidence sources improves prediction accuracy, as seen in tools 
such as PrePPI (Zhang et al. 2012) that combines three-dimensional structural and 
functional information.  Repositories such as STRING (Snel et al. 2008, Szklarczyk et al. 
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2015) [Fig. 1.6.1], PIPs [Fig. 1.6.2] and other contain information on PPIs from different 
evidence sources. 
 




STRING (Snel et al. 2008, Szklarczyk et al. 2015) is a repository of both known and 
predicted physical and functional PPIs.  Predicted interactions are obtained from 
different evidence sources.  
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Figure 1.6.2: The PIPs repository 
 
  
The PIPs database is a PPI prediction repository that combines predicted data from 
different evidence sources. 
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1.7 – Text Mining 
 
Text mining, or information extraction, is automated extraction of structured 
information from text using bioinformatics and machine-learning algorithms.  It can help 
to quickly uncover hidden or previously unknown information in high volumes of 
unstructured text without human intervention.  The most prominent example of this type 
of text mining is a web search engine such as Google, which extracts information based 
on keywords from a repository of websites (Hill and Lewicki 2007).  In biology, text 
mining of large volumes of published data is applied to assist biologists in quickly 
uncovering information.  An example of the application of text mining in biology is the 
‘Related Articles’ function in PubMed, where a content similarity algorithm is used to 
retrieve articles similar to the search term (Lin and Wilbur 2007). 
 
At the basis of text mining is Named Entity Recognition (NER) – a strategy for 
identifying the terms (entities) in question.  NER is a technique to recognize concepts in 
text that follow a selected form.  Statistical methods and machine-learning techniques, 
such as support vector machines (SVMs) (Takeuchi and Collier 2002), Hidden Markov 
Models (HMM), Maximum Entropy (ME), and Conditional Random Fields (CRF are 
then applied to extract and analyze the NER results. 
 
This Masters work describes the use of text mining of PubMed abstracts as a 
novel evidence source for WW domain-mediated PPIs. 
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1.8 – Precision and Recall 
 
 To evaluate the performance and utility of computational prediction algorithms, it 
is necessary to determine how well the algorithm retrieves results that are true and how 
well it discards results that are false.  Two standard statistical measurements to compute 
these ratios are precision and recall.  Precision refers to the fraction of true positives out 
of all predictions.  Recall describes the fraction of true positives out of everything in the 
benchmark.  ‘True positives’ refers to prediction results that have been proven true – in 
our case, a true positive would be a predicted interaction that has been experimentally 
validated and shown to occur in vivo.  Correspondingly, ‘false positives’ refer to results 
that have been predicted true by the algorithm, but are actually false (in our case – 
predicted interactions that have not been experimentally verified).  A repository of 
known, experimentally validated interactions serves as a ‘benchmark’.  In this work, the 
benchmark is the iRefIndex version 9 repository of PPIs obtained using different 
experimental methods. 
 
1.9 – Thesis Outline 
 
The first chapter of the thesis describes my work on gene name co-occurrence in 
PubMed abstracts.  I programmatically searched these abstracts for co-occurrence of gene 
symbols of WW domain-containing proteins and evaluated these predictions statistically, 
by setting a cutoff for the number of abstracts and plotting a precision-recall graph.  I 
then proceeded to examine the Medical Subject Heading (MeSH) terms indexed in those 
articles and compared the results to previous findings.  This work is outlined in Chapter 
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2.  Finally, I refined the co-occurrence prediction approach by introducing a controlled 
vocabulary into the search (Chapter 3).  All results are presented graphically in figures 
throughout the thesis.  Python scripts used in the process are presented in the Appendix. 
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CHAPTER 2.  GENE NAME CO-OCCURRENCE 
 
Co-occurrence based methods are one common technique in text mining to predict 
and construct PPI networks (Jenssen et al. 2001, Cohen and Hunter 2008).  Concepts that 
are mentioned within the same unit of text, such as sentence or paragraph, are predicted 
to also have a biological affiliation (Krallinger et al. 2008).  In protein interaction 
predictions, the co-occurring terms may be gene names, gene symbols, GO terms (Jain 
and Bader 2010) or MeSH terms (Jenssen et al. 2001).  Co-occurrence can be used as 
computational evidence of biological association.  In the STRING repository, co-
occurrence of genes serves as an indication of functional relation (Snel B 2008). 
 
Research has been done in the Bader lab to predict PRM-mediated PPIs involving 
SH3 and PDZ domain family members, using GO terms as an evidence source.  Jain et al. 
(2010) predicted that proteins with similar GO gene function annotation also potentially 
interact in vivo.  The procedure described below identifies co-occurring human gene 
symbols in PubMed abstracts to be used as an evidence source for WW-mediated PPI 
predictions. The confidence measure is the number of co-occurrences for protein names 
in question; i.e. the higher the number of abstracts where these protein names co-occur, 
the more likely these proteins are to interact in vivo.   
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2.1 – MATERIALS AND METHODS 
 
The Python programming language was selected as the language for writing 
custom text mining scripts, since it is a language that I am extensively familiar with, as 
well as one of the preferred languages for bioinformatics analyses, with its built-in Bio 
and EUtils libraries.  In addition, Python is open-source, lightweight for installation 
and configuration on UNIX-like platforms, easy to learn and execute.   
 
Scripts written in Python are executed in UNIX-like environments, such as Linux 
or Mac.   
 
As an auxiliary resource, a custom database [Appendix A] was constructed, using 
the MySQL database management system (DBMS), by virtue of its being open-source, 
freely available, flexible for installation on different operating systems (OS), including 
Linux and Mac, and my extensive familiarity with it. 
 
The iRefIndex (Turner et al. 2010)	  database	  was	  used	  as the benchmark, since it 
contains information on both predicted and experimentally verified PPIs, which can be 
either direct or indirect, physical or chemical, and detected using various methods.  
iRefIndex integrates information on PPIs from different databases, including BIND, 
BioGrid, DIP, HPRD, MPPI, OPHID and more.  The iRefWeb web interface lets the user 
select the number of databases where PPIs were observed (1 or more, 2 or more, 3 or 
more).  iRefIndex was selected as the benchmark set, as it includes interactions from 
different databases obtained using different experimental methods.  Other PPI 
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repositories, such as HPRD, do not include data from multiple evidence sources, and, 
hence, provide less information than iRefIndex. 
 
2.2 – PROCEDURE  	  
2.2.1.  Datasets: 
The text mining process started with downloading the following datasets: 
 
-­‐ A list of all approved official HGNC symbols for every protein-coding gene in the 
human genome (32717 in total) in text format – Set A 
 
-­‐ A list of 50 gene symbols of WW domain-containing proteins, downloaded from 
Ensembl (http://ensembl.org) using the Biomart query system (Smedley et al. 2009, 
Zhang et al. 2011)	  in	  text	  format	  – Set B (Appendix B)	  
 
-­‐ A set of all PubMed abstracts for every WW-containing protein in Set B, excluding 
DMD and ITCH.  The abstracts can be retrieved using the built-in ‘esearch’ and 
‘efetch’ methods of the Entrez	   Programming	   Utilities	   Python package (EUtils) 
(National Center for Biotechnology Information (US) 2008),	   or,	   alternatively,	  downloaded	   directly	   from	   PubMed.  DMD and ITCH were excluded from the 
search, since the number of abstracts matching these terms exceeds 1000, and the 
script times out. (Appendix C).  Appendix D contains a Python script to parse the 
XML results and store them in the database. 
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-­‐ A list of 1722 interacting protein pairs, in text format, downloaded from the iRefWeb 
(iRefIndex database version 9) in	  full	  MITAB	  format.	  
 
To obtain the benchmark dataset, the iRefWeb site 
http://wodaklab.org/iRefWeb/search/index was searched using the following 
parameters: 
 
-­‐ Source database: ANY 
 
-­‐ Organism: Single organism interaction, Homo sapiens 
 
-­‐ Nature of Interactions: Pairwise, experimental, physical 
 
-­‐ Number of Publications: 1 or more publications 
 
The interacting protein pairs – were downloaded in MITAB format.  MITAB is the 
standard format for biological data exchange, as specified by the Human Proteome 
Organization (HUPO) Proteomics Standard Initiative (PSI).   
 
 
The downloaded MITAB file contains the following information: 
( http://psidev.sourceforge.net/molecular_interactions/xml/doc/user/)  
 
Columns 1 and 2:  
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uidA uidB  
Unique identifiers, mainly ‘UniProtKB’, of the interacting proteins: 
e.g. uniprotkb:Q05193      uniprotkb:P60880 
 
Columns 3 and 4:  
altA altB  






Columns 5 and 6:  
aliasA aliasB   
List of aliases for the interacting proteins, separated by |.   
e.g. 
uniprotkb:DYN1_HUMAN|entrezgene/locuslink:DNM1|crogid:uiP8CXhKWQa
P2GIAZULJTLqwGLs9606|icrogid:4370876    
This is the input I used for my benchmark, since it contains values in the form 
GENESYMBOL_HUMAN.  In this work, all values that contain the term ‘HUMAN’ 
were extracted from the MITAB file; built-in UNIX commands and VI editor were used 
to remove all other information. 
 
Column 7:  
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method - Interaction detection methods, separated by | 
 
Column 8:  
author – Author(s) of publications where this interaction was shown, separated by | 
Column 9: 
pmids – PubMed IDs of publications where this interaction was shown, separated by | 
 
Columns 10 and 11: 
taxa taxb – NCBI taxonomy identifiers for interactors A and B  
The remaining columns are internal iRefWeb identifiers and scores, not used in this work.  	   
Alternatively, interaction data may be downloaded from iRefWeb in MITAB-lite format, 
which contains condensed information.  Since it contains no protein names, only internal 
identifiers, it was not used as a benchmark in this work.   
 
The benchmark set was downloaded in the full MITAB format, and all information not 
pertaining to WW domain-containing protein interaction was removed using the Python 
programming language (ww_benchmark.py), as well as standard UNIX commands and 
the built-in VI editor. 
 
The final benchmark set contains 1722 interacting protein pairs (this number has likely 
increased since 2012) ww_benchmark.tsv – Appendix E.  
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2.2.2.  Text mining: 
 
Once the datasets were downloaded, Python scripts were written and executed to extract 
protein names from PubMed abstracts.  Proteins whose names were mentioned in the 
same abstract were predicted to interact.  The interacting pair, along with the PubMed 
publication IDs (PMIDs) of the abstracts where the interaction was found, were recorded 




- co_occurrence.py:  (Appendix F) 
 
Contains the script to identify PubMed abstracts where a WW-containing protein and 
any other proteins from the set of HUGO gene symbols co-occur 
(approved_hgnc_symbol_biomart.txt).  The pair of protein names is recorded as a 
predicted interaction, along with the PMID of the abstract where they were found. 
 
Recorded interactions were grouped by the number of abstracts where the interaction was 
found and verified against the benchmark (Appendix G) to reveal TPs and FPs.  A 
predicted interaction that was also found in the benchmark was recorded as a TP.  An 
interaction that was predicted but did not appear in the benchmark was recorded as a FP.  
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2.3 – RESULTS   
 
Figure 2.3.1: Example of protein name co-occurrence in abstracts. 
 
 
Smurf1, Smurf2, Smad1, Smad 2 and Smad7 gene names co-occur in this abstract.  
These proteins are also listed as interacting partners in GeneMANIA (Mostafavi et 
al. 2008, Warde-Farley et al. 2010), as illustrated in Figure 2.3.2.   
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Figure	   2.3.2	   has	   been	   obtained	   using	   the	   GeneMANIA	   visualization	   tool,	   which	  illustrates	  protein	  interactions	  of	  different	  types	  (direct	  or	  indirect).	  	  The	  strength	  of	  interactions	   corresponds	   to	   the	   thickness	   of	   lines	   connecting	   the	   proteins	   in	  question.	  
Figure 2.3.2: A diagram illustrating the interaction between Smurf1, Smurf2, 
Smad1, Smad2 and Smad7 proteins from the GeneMANIA prediction server 
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Figure 2.3.3: An abstract describing the interaction of Smurf2 and Smad1 proteins 
in vivo (Zhang et al. 2001). 
Smad proteins are key intracellular signaling effectors for the transforming growth 
factor-β superfamily of peptide growth factors. Following receptor-induced 
activation, Smads move into the nucleus to activate transcription of a select set of 
target genes. The activity of Smad proteins must be tightly regulated to exert the 
biological effects of different ligands in a timely manner. Here, we report the 
identification of Smurf2, a new member of the Hect family of E3 ubiquitin ligases. 
Smurf2 selectively interacts with receptor-regulated Smads and preferentially 
targets Smad1 for ubiquitination and proteasome-mediated degradation. At higher 
expression levels, Smurf2 also decreases the protein levels of Smad2, but not Smad3. 
In Xenopusembryos, ectopic Smurf2 expression specifically inhibits Smad1 
responses and thereby affects embryonic patterning by bone morphogenetic protein 
signals. These findings suggest that Smurf2 may regulate the competence of a cell to 
respond to transforming growth factor-β/bone morphogenetic protein signaling 
through a distinct degradation pathway that is similar to, yet independent of, 
Smurf1. 
 
Proc Natl Acad Sci U S A. 2001	  Jan	  30;98(3):974-­‐9.	  
 
Regulation of Smad degradation and activity by Smurf2,	  an E3 ubiquitin ligase.	  
Zhang Y1, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R.	  
 PMID:	  11158580	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Figure 2.3.4: An abstract describing the interaction of Smurf2 and Smad1 proteins 
in vivo (Fukasawa et al. 2004). 
Overexpression of transforming growth factor beta (TGF-β) has been shown to play 
pathogenic roles in progression of renal fibrosis, and the severity of tubulointerstitial 
fibrosis correlates better with renal function than the severity of glomerulosclerosis. 
Smad proteins are signaling transducers downstream from TGF-β receptors. Three 
families of Smad proteins have been identified: receptorregulated Smad2 and Smad3, 
common partner Smad4, and inhibitory Smad7 (part of a negative-feedback loop). We 
investigated Smad-mediated TGF-β signaling pathway and regulatory mechanisms of 
inhibitory Smad7 in unilateral ureteral obstruction (UUO) kidneys in mice, a model of 
progressive tubulointerstitial fibrosis. Compared with sham-operated kidneys, the level of 
Smad7 protein, but not mRNA, decreased progressively in UUO kidneys, whereas 
immunoreactivity for nuclear phosphorylated Smad2 and Smad3 and renal fibrosis were 
inversely increased. Furthermore, we demonstrated that both the degradation and 
ubiquitination activity of Smad7 protein were increased markedly in UUO kidneys 
compared with sham-operated ones. We also found that both Smurf1 and Smurf2 (Smad 
ubiquitination regulatory factors), which are E3 ubiquitin ligases for Smad7, were 
increased and that they interacted with Smad7 in UUO kidneys. Our results suggest that 
the reduction of Smad7 protein resulting from enhanced ubiquitin-dependent degradation 
plays a pathogenic role in progression of tubulointerstitial fibrosis. 
	  
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8687-92. Epub 2004 Jun 1. 
 
“Down-regulation of Smad7 expression by ubiquitin-
dependent degradation contributes to renal fibrosis in obstructive nephropathy in 
mice.” 	  
Fukasawa H1, Yamamoto T, Togawa A, Ohashi N, Fujigaki Y, Oda T, Uchida C, Kitagawa K, Hattori 
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Figure 2.3.5: An abstract describing the interaction of Smurf2 and Smad1 proteins 
in vivo (Lin et al. 2000) 
Smads are important intracellular signaling effectors for transforming growth factor-beta (TGF-
beta) and related factors. Proper TGF-beta signaling requires precise control of Smad functions. 
In this study, we have identified a novel HECT class ubiquitin E3 ligase, designated Smurf2, that 
negatively regulates Smad2 signaling. In both yeast two-hybrid and in vitro binding assays, we 
found that Smurf2 could interact with receptor-activated Smads (R-Smads), including Smad1, 
Smad2, and Smad3 but not Smad4. Ectopic expression of Smurf2 was sufficient to reduce the 
steady-state levels of Smad1 and Smad2 but not Smad3 or Smad4. Significantly, Smurf2 
displayed preference to Smad2 as its target for degradation. Furthermore, Smurf2 exhibited 
higher binding affinity to activated Smad2 upon TGF-beta stimulation. The ability of Smurf2 to 
promote Smad2 destruction required the HECT catalytic activity of Smurf2 and depended on the 
proteasome-dependent pathway. Consistent with these results, Smurf2 potently reduced the 
transcriptional activity of Smad2. These data suggest that a ubiquitin/proteasome-dependent 
mechanism is important for proper regulation of TGF-beta signaling. 
 
 
J Biol Chem. 2000	  Nov	  24;275(47):36818-­‐22.	  	  
“Smurf2	  is	  a	  ubiquitin	  E3	  ligase	  mediating	  proteasome-­‐dependent	  
degradation	  of	  Smad2	  in transforming growth factor-beta signaling.”	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Precision and Recall 
 
A standard measure for evaluating the accuracy of bioinformatics methods is 
precision and recall computation.  Precision, also known as ‘specificity’, is the fraction of 
true positives out of all predictions.  Recall, also referred to as ‘sensitivity’, is the fraction 
of true positives out of everything in the benchmark.  Precision and recall are computed 
according to the following formulas: 
 
Precision = TP / (TP + FP)	  
Recall = TP / (TP + FN),  
 
‘TP’ and ‘FP’ represent the number of true positives and false positives in the prediction 
set. 
 
In this work, predictions were grouped by the number of abstracts in which they 
were encountered.  For every predicted interacting protein pair, the number of abstracts in 
which this prediction was encountered was also recorded.  The higher the number of 
abstracts in which a given protein pair was encountered, the higher the likelihood that 
these proteins interact in vivo.  Ideally, precision and recall would grow as the abstract 
cutoff increases. 
 
Since the obtained precision and recall values are less than 1.0, they have been 
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Table 2.3.6: WW domain-containing protein interactions, grouped by the number of 
abstracts cutoff. 
# abstracts True positives False positives Total predictions 
False 
negatives 
    
 
>=1 225 2236 2461 1497 
>=2 130 721 851 1592 
>=3 89 362 451 1633 
>=4 78 254 332 1644 
>=5 61 193 254 1661 
>=6 52 108 160 1670 
>=7 44 81 125 1678 
>=8 39 63 102 1683 
>=9 33 50 83 1689 
>=10 30 42 72 1692 
>=11 28 35 63 1694 
>=12 27 31 58 1695 
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Table 2.3.7: WW domain-containing protein interaction prediction results based on 
co-occurrence of protein names in PubMed abstracts (2012) 
 
# abstracts cutoff  Recall Precision 
>=1 0.1307 0.0914 
>=2 0.0868 0.1528 
>=3 0.0651 0.1973 
>=4 0.0610 0.2349 
>=5 0.0508 0.2402 
>=6 0.0457 0.3250 
>=7 0.0405 0.3520 
>=8 0.0374 0.3824 
>=9 0.0329 0.3976 
>=10 0.0309 0.4167 
>=11 0.0298 0.4444 
>=12 0.0296 0.4655 
 
 
As evident from this figure, precision drops as the abstract cutoff decreases.  Recall 
is also low at high precision. 
 
The resulting precision-recall graph is shown in Fig. 2.3.8. 
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Figure 2.3.8: Precision-recall graph of WW domain-containing PPI predictions by 
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2.4 – DISCUSSION  
 
The main problem with text mining by gene name co-occurrence, besides long 
execution time, is ambiguity.  For gene names that match a dictionary word, such as 
ITCH, PubMed search returns all abstracts that contain this word and its derivatives 
(‘itchy skin’, ‘itching’, etc.), not necessarily the protein name.  The same applies to gene 
names consisting of one or two characters, such as ‘T’ or ‘TH’, which form parts of 
English words, and gene names equivalent to disease name abbreviations, such as ‘MS’.  
The number of PubMed abstracts returned for these genes exceeds several thousand, 
resulting in a high number of false positives, which, in turn, lead to low recall. 	  
 
2.5 – CONCLUSIONS  
 
Text mining by gene name co-occurrence in PubMed abstracts is successful in predicting 
interacting protein pairs with precision rate between approximately 0.1 and 0.5, and recall 
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CHAPTER 3:  MeSH TERM INDEXING 
 
To resolve the issue of ambiguity mentioned in 2.4, I needed to refine the search 
to limit the number of abstracts returned by the search to abstracts that specifically talk 
about this gene name.  For this, I used the Medical Subject Heading (MeSH) term 
indexing. 
 
The Medical Subject Heading (MeSH) database is a controlled vocabulary of the 
U.S. National Library of Medicine that uniformly indexes biomedical literature (NIH: 
U.S. National Library of Medicine 2012).  The MeSH vocabulary includes four main 
types of terms: Headings (descriptors), Subheadings (qualifiers), Supplementary 
Concepts, and Publication Types (NIH: U.S. National Library of Medicine 2012).  These 
terms characterize different aspects of the published MeSH records and are classified as Descriptors,	   Qualifiers,	   or	   Supplementary	   Concept	   Records	   (SCRs)	   (NIH:	   National	  Library	  of	  Medicine	  2014).	  	  For human protein names, the MeSH terms are in the form 
“official_gene_symbol protein, human” (e.g. ‘BAG3 protein, human’) and are indexed 
in PubMed abstracts as either ‘Supplementary Concepts’ or ‘Entry terms’. 	  
 
MeSH term indexing facilitates searching PubMed by retrieving only publications 
that discuss the search term substantively.  A publication that simply mentions a concept 
but does not discuss it in detail is not indexed with a MeSH term for this concept and will 
not be returned by the search.  Hence, using the MeSH Supplementary Concept indexing 
of protein names to retrieve only articles that specifically discuss these proteins and their 
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interacting partners is expected to increase search precision considerably, compared to 
only searching for simple gene name mentions. 
 
3.1 – MATERIALS AND METHODS	  
 
3.1.1.  Datasets: 
The text mining process started with the following datasets: 
 
-­‐ A list of all approved official HGNC symbols for every protein-coding gene in the 
human genome (32717 in total) in text format – Set A 
 
-­‐ A list	  of	  50	  gene	  symbols	  of	  WW	  domain-­‐containing	  proteins,	  downloaded	  from	  
Biomart	   (Smedley	   et	   al.	   2009,	   Zhang	   et	   al.	   2011)	   in	   text	   format	   –	   Set	   B	  
(Appendix	  B)	  
 
-­‐ A list of MeSH terms for all genes from Set A and Set B.  These terms may be 
retrieved in batch from the MeSH database using Python EUtils package as follows: 
 
handle = Entrez.esearch(db="mesh", term=prot, rettype='xml',  
retmax=ret_max) 	   A	   unique	  MeSH	   supplementary	   concept	   term	  was	   found	   for	   44	   of	   the	   50	  WW	  domain-­‐containing	  proteins.	   	  Of	  the	  remaining	  6	  proteins,	  5	  have	  not	  been	  indexed	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for	  MeSH,	  and	  the	  MeSH	  supplementary	  concept	  for	  DRP2	  is	  not	  in	  the	  format	  ‘DRP2	  protein,	  human’	  and	  was	  excluded	  from	  the	  search.	  
 The returned abstract set corresponds to the results of a generalized manual search 
of PubMed using the MeSH term as a search keyword.  Alternatively,	  the	  MeSH	  terms	  may	   be	   downloaded	   manually	   in	   XML	   format	   from	   the	   MeSH	   repository.	   	   Then	  Python	   and/or	   UNIX	   commands	  would	   be	   used	   to	   extract	   the	   protein	   names	   and	  their	  corresponding	  MeSH	  terms	  from	  the	  downloaded	  file,	  in	  the	  form	  “gene_name	  protein,	  human”	  (e.	  g.	  “A1CF	  protein,	  human”,	  which	  corresponds	  to	  the	  ‘A1CF’	  gene	  symbol).	   	   	   	  However,	   the script’s execution time using MEDLINE is many times faster 
than retrieving the records as XML or plain text.   
 The	  retrieved	  MeSH	  terms	  were	  stored	  in	  a	  MySQL	  database.	  	  
 
-­‐ A set of all PubMed abstracts for every WW-containing protein in Set B, excluding 
DMD and ITCH, since they were not included in part 1 of the analysis.  The abstracts 
were retrieved using the built-in ‘esearch’ and ‘efetch’ methods of the Entrez	  Programming	  Utilities	  Python package (EUtils) (National Center for Biotechnology 
Information 2008). 	  	   Alternatively,	   the	   abstracts	   can	   be	   downloaded	  manually	   from	   the	  NLM	  MeSH	  website:	  http://www.nlm.nih.gov/mesh/filelist.html.  Either of these techniques may 
be implemented for use in the future in an automated prediction pipeline.  Approach 
a) requires no human interaction, whereas approach b) requires human effort. 
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The retrieved abstracts with their PMIDs were stored in a MySQL database. 
 
-­‐ A list of 1722 interacting protein pairs, in text format, downloaded from iRefWeb in	  full	  MITAB	  format	  (same	  as	  in	  Chapter	  2)	  using	  the	  script	  from	  Appendix E.	  
 
Computational resources are the same as in Chapter 2. 
 
3.1.2.  Text mining: 
 
Once the datasets were downloaded, Python scripts were written and executed to 
find the MeSH terms for protein names from Set A from the downloaded PubMed 
abstracts.  Proteins whose corresponding MeSH terms were indexed in the same abstract 
were predicted to interact.  The interacting pair, along with the PubMed publication IDs 
(PMIDs) of the abstracts in which the interaction was found, were recorded in a tab-
delimited file.  Interactions were then grouped by number of abstracts where each 
interaction was found (similar to Chapter 2), precision and recall were computed, and a 




- mesh_search.py:  (Appendix I) 
 
	  	   44	  
Contains code to download the MeSH term for every human protein-coding gene 
symbol.  The script accesses the MeSH repository remotely.  Retrieved MeSH term 
records were stored in a MySQL database 
 
-	  eutils_search.py:  
 
This script does two things:  
a) Search PubMed remotely for all abstracts pertinent to each WW-containing 
protein from Set B. 	  	  
b) In every abstract, identify all MeSH terms indexed in it, both for WW-
containing proteins and any other proteins from the set of HUGO gene 
symbols.  All MeSH terms were recorded in the database as predicted 
interacting partners, along with the PMID of the abstract where they were 
found. 
 
The resulting interaction dataset was stored in the database. 
 
Table 3.1.1: A sample MySQL table storing mapping between HGNC symbols and 
their corresponding MeSH terms: 
MeSH Term Gene Symbol 
UTRN protein, human  UTRN 
DMD protein, human  DMD 
ARHGAP27 protein, human ARHGAP27 
GAS7 protein, human  GAS7 
ITCH protein, human ITCH 
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Table 3.1.2: A sample MySQL table storing predicted interactions for MeSH terms 
indexed in the same abstract. 
Source MeSH Term Interacting Partner PMID of abstracts where interactions were found 
GAS7 protein, human RUNX2 protein, 
human 
21452305            




human 22351504,20937913, 20484049 
 
 
Table 3.1.3: WW domain-containing protein interaction prediction results based on 
MeSH term indexing in PubMed abstracts (2013) 
# Abstracts True positives False positives Total predictions False negatives 
>=1 85 556 641 1637 
>=2 25 70 95 1697 
>=3 7 20 27 1715 
>=4 3 8 11 1719 
>=5 2 3 5 1720 
>=6 1 1 2 1721 
>=7 1 1 2 1721 
>=8 1 1 2 1721 
>=9 1 0 1 1721 
>=10 1 0 1 1721 
>=11 1 0 1 1721 
>=12 1 0 1 1721 
 
Table 3.1.4: Precision and recall computed for results in Fig. 3.1.3 
 
# abstracts cutoff  Recall Precision 
>=1 0.0494 0.1326 
>=2 0.0145 0.2632 
>=3 0.0041 0.2593 
>=4 0.0017 0.2727 
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>=5 0.0012 0.4000 
>=6 0.0006 0.5000 
>=7 0.0006 0.5000 
>=8 0.0006 0.5000 
>=9 0.0006 1.0000 
>=10 0.0006 1.0000 
>=11 0.0006 1.0000 
>=12 0.0006 1.0000 
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Figure 3.1.5: Precision-recall graph of WW domain-containing PPI predictions by 
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Table 3.1.6: Comparison of text mining prediction results based on gene name co-
occurrence in abstracts and results based on MeSH term indexing 
 
 
Gene name co-occurrence MeSH terms 
Abstracts Recall Precision Recall Precision 
>=1 0.1307 0.0914 0.0494 0.1326 
>=2 0.0868 0.1528 0.0145 0.2632 
>=3 0.0651 0.1973 0.0041 0.2593 
>=4 0.0610 0.2349 0.0017 0.2727 
>=5 0.0508 0.2402 0.0012 0.4000 
>=6 0.0457 0.3250 0.0006 0.5000 
>=7 0.0405 0.3520 0.0006 0.5000 
>=8 0.0374 0.3824 0.0006 0.5000 
>=9 0.0329 0.3976 0.0006 1.0000 
>=10 0.0309 0.4167 0.0006 1.0000 
>=11 0.0298 0.4444 0.0006 1.0000 
>=12 0.0296 0.4655 0.0006 1.0000 
 
 
A comparison of both curves is illustrated in Fig. 3.1.7. 
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Figure 3.1.7: Comparison of text mining results based on gene name co-occurrence 
to results based on MeSH term indexing. 
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3.1.3 – DISCUSSION  	  
The main disadvantage of using MeSH indexing for PPI prediction is the lack of 
indexing for many proteins that are not a major topic of an article.  If a protein has not 
been indexed for MeSH, it would not be considered an interacting partner, even though it 
might be a TP.  
 
3.1.4 – CONCLUSIONS  
 
 
Text mining results based on MeSH term indexing show much greater precision 
than results based on gene name co-occurrence, as expected, due to stringent definition of 
MeSH terms and publication indexing in PubMed.  However, the recall is much lower 
than recall using gene name co-occurrence.  Many proteins that interact in real life and 
are co-mentioned in abstracts but are not major topics of publications are not indexed for 
MeSH.  For this reason, a script that relies on MeSH term indexing to predict protein 
interactions returns a high number of false negatives, i.e. predictions are simply missed.  
MeSH terms can, therefore, be used for PubMed text mining in cases where high 
precision is required; however, due to the low recall, it is not worthwhile to use MeSH 
terms for large-scale text mining. 
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CHAPTER 4.  CO-OCCURRENCE WITH CONTROLLED 
VOCABULARY 
 
Since MeSH term search yielded poor recall, the final step of the analysis reverts 
to gene name co-occurrence.  To improve precision by reducing the number of false 
positives and predict interactions that specifically involve the WW domain, a controlled 
vocabulary has been applied to identify specific interactions mediated by the WW 
domain. 
 
The controlled vocabulary terms have been selected manually based on known 
WW PPI abstracts, to reflect WW domain-mediated interactions to the domain’s binding 
motif.  The list includes the following terms: 
 
-­‐ proline-rich 
-­‐ protein-protein interaction 
-­‐ WW domain 
-­‐ proline residues 
-­‐ PPxY 
-­‐ LPxY 
-­‐ protein interaction module 
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4.1.  MATERIALS AND METHODS 
 
4.1.1.  Datasets: 
The text mining process started with the following datasets: 
 
-­‐ A list of all approved official HGNC symbols for every protein-coding gene in the 
human genome (32717 in total) in text format – Set A 
 
-­‐ A list of 50 gene symbols of WW domain-containing proteins, downloaded from 
Biomart (Smedley et al. 2009, Zhang et al. 2011) in text format – Set B (Appendix 
B) 	  
-­‐ A	  list	  of	  controlled	  vocabulary	  terms	  –	  Set	  	  C	  
 
Set C:  Controlled vocabulary terms 
-­‐ proline-rich 
-­‐ protein-protein interaction 
-­‐ WW domain 
-­‐ proline residues 
-­‐ PPxY 
-­‐ LPxY 
-­‐ protein interaction module 
-­‐ WW domain-binding 
-­‐ WW-binding 
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-­‐ A set of all PubMed abstracts for every WW-containing protein in Set B, 
excluding DMD and ITCH, since they were not included in part 1 of the 
analysis.  The abstracts were retrieved using the built-in ‘esearch’ and ‘efetch’ 
methods of the Entrez	   Programming	   Utilities	   Python package (EUtils) 
(National Center for Biotechnology Information (US) 2008)	  –and stored in a 
custom MySQL database.	  	   Alternatively,	   the	   abstracts	   can	   be	   downloaded	  manually	   from	   the	  NLM	  MeSH	  website:	  http://www.nlm.nih.gov/mesh/filelist.html.  Either of these techniques may 
be implemented for use in the future in an automated prediction pipeline.  Approach 
a) requires no human interaction, whereas approach b) requires human effort. 
 
Computational resources (UNIX, Python, MySQL) are the same as in Chapters 2 and 3. 
 
4.1.2. Text mining: 
 
For each controlled vocabulary term, abstracts that contain this term, were 
selected for analysis.  Remaining abstracts were discarded. 
 
An example of such an abstract is shown in Fig. 4.1.1 
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Figure 4.1.1: An abstract that contains controlled vocabulary term 
‘PHOSPHORYLATION’.  Co-occurring protein names HSF1 and BAG3 are 
highlighted.  These proteins were predicted to interact. 
PMID: 23983126 
 
Heat shock factor 1 (HSF1) enhances the survival of cancer cells under various 
stresses. The knock-out of HSF1 impairs cancer formation and progression, 
suggesting that HSF1 is a promising therapeutic target. To identify inhibitors of 
HSF1 activity, we performed cell-based screening with a library of marketed and 
experimental drugs and identified cantharidin as an HSF1 inhibitor. Cantharidin is 
a potent antitumor agent from traditional Chinese medicine. Cantharidin inhibited 
heat shock-induced luciferase activity with an IC50 of 4.2 xcexbcm. In contrast, 
cantharidin did not inhibit NF-xcexbaB luciferase reporter activity, demonstrating 
that cantharidin is not a general transcription inhibitor. When the HCT-116 
colorectal cancer cells were exposed to heat shock in the presence of cantharidin, the 
induction of HSF1 downstream target proteins, such as HSP70 and BAG3 (Bcl-2-
associated athanogene domain 3), was suppressed. HSP70 and its co-chaperone 
BAG3 have been reported to protect cells from apoptosis by stabilizing anti-
apoptotic Bcl-2 family proteins. As expected, treating HCT-116 cancer cells with 
cantharidin significantly decreased the amounts of BCL-2, BCL-xL, and MCL-1 
protein and induced apoptotic cell death. Chromatin immunoprecipitation analysis 
showed that cantharidin inhibited the binding of HSF1 to the HSP70 promoter and 
subsequently blocked HSF1-dependent p-TEFb recruitment. Therefore, the p-
TEFb-dependent phosphorylation of the C-terminal domain of RNA polymerase II 
was blocked, arresting transcription at the elongation step. Protein phosphatase 2A 
inhibition with PP2CA siRNA or okadaic acid did not block HSF1 activity, 
suggesting that cantharidin inhibits HSF1 in a protein phosphatase 2A-independent 




Proteins HSF1 and BAG3, which co-occur in the referenced article, also interact in vivo, 
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Figure 4.1.2:  A Cytoscape (Shannon et al. 2003) diagram illustrating the interaction 
between BAG3 and HSF1 proteins 
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Interacting protein pairs and the PMIDs of the abstract where they co-occur were 
stored in a MySQL database.  Again, co-occurrences were grouped by the number of 
abstracts, and a precision-recall graph was constructed. 
 
The script was first run for each controlled vocabulary (CV) term; then a 
combined prediction script was run for all the CV terms. 
 
Prediction statistics using co-occurrence with CV terms and comparison to 
previous text mining results are shown in Fig. 4.1.4 – 4.1.8. 
 
Table 4.1.3:  The number of TPs and FPs for each individual CV term  
 
Term Total predictions TP FP 
LPxY 1 0 1 
PPxY 93 23 70 
Proline residues 8 1 7 
Proline-rich 45 9 36 
Protein interaction 56 15 41 
PXXP 1 0 1 
WW-binding 9 2 7 
WW domain 321 74 247 
WW domain-binding 4 2 2 
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  >= abstracts Recall Precision 
  >=1   0.0065   0.2245 
  >=2   0.0012   0.4000 
  >=4   0.0006   1.0000 
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Figure 4.1.5:  Precision-recall table and graph for CV term ‘WW domain’ 
 
abstract cutoff Recall Precision 
>=1 0.0306 0.2271 
>=2 0.0094 0.2807 
>=3 0.0029 0.2500 







	  	   59	  



















  >= abstracts Recall Precision 
  >=1   0.0106   0.2903 
  >=2   0.0024   0.2857 
  >=3   0.0006   0.2000 
  >=4   0   0 
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>=1$ 288$ 60$ 228$ 0.0348$ 0.2083$
>=2$ 74$ 21$ 53$ 0.0122$ 0.2838$
>=3$ 27$ 7$ 20$ 0.0041$ 0.2593$
>=4$ 14$ 2$ 12$ 0.0011$ 0.1429$
>=5$ 7$ 1$ 6$ 0.0006$ 0.1429$
>=7$ 3$ 1$ 2$ 0.0006$ 0.3333$
>=9$ 2$ 1$ 1$ 0.0006$ 0.5000$
>=15$ 1$ 0$ 1$ 0$ 0$!
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Figure 4.1.9:  Comparison of precision and recall values for gene name co-
occurrence with and without all CV terms combined 
 
 
Gene name co-occurrence 
without CV 
Gene name co-occurrence 
with CV 
Abstracts Recall Precision Recall Precision 
>=1 0.1307 0.0914 0.0348 0.2083 
>=2 0.0868 0.1528 0.0122 0.2838 
>=3 0.0651 0.1973 0.0041 0.2593 
>=4 0.0610 0.2349 0.0012 0.1429 
>=5 0.0508 0.2402 0.0006 0.1429 
>=6 0.0457 0.3250 0.0006 0.1429 
>=7 0.0405 0.3520 0.0006 0.3333 
>=8 0.0374 0.3824 0.0006 0.3333 
>=9 0.0329 0.3976 0.0006 0.5 
>=10 0.0309 0.4167 0 0 
>=11 0.0298 0.4444 0 0 
>=12 0.0296 0.4655 0 0 
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Figure 4.1.10:  Comparison of all text mining results – based on gene name co-
occurrence without CV, based on MeSH terms, and based on gene name co-















MeSH	  Terms	  Gene	  Name	  Co-­‐occurrence	  CV	  combined	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4.2.  DISCUSSION 
 
As expected, text mining based on co-occurrence with CV yields higher precision 
and higher recall than co-occurrence without CV.  It also yields higher precision than 
MeSH term-based mining.  It shows lower recall than MeSH term-based mining, which 
can be explained by two factors.  The first is the stringency of CV selection – like MeSH 
term definition, the CV algorithm may discard relevant abstracts that contain information 
on PPIs but not the CV terms.   
 
As outlined in section 2.4, it would be helpful to rerun the prediction script with a 
new version of iRefIndex and ensure that the publications examined by the script are not 
newer than the latest version of the benchmark.  This step may help identify more TPs 




4.3.  CONCLUSIONS 	  Based	  on	  the	  precision-­‐recall	  graph	  for	  gene	  name	  co-­‐occurrence	  with	  CV,	  it	  may	  be	  concluded	  that	  gene	  name	  co-­‐occurrence	  is	  a	  text	  mining	  algorithm	  that	  can	  be	  used	  as	  a	  novel	  evidence	  source,	  for	  PPIs	  that	  involve	  the	  WW	  domain	  and	  for	  other	  PPIs.	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FUTURE DIRECTIONS 
 
It would be helpful to consider gene name aliases.  Since many proteins are listed 
in HGNC under multiple names, or their names have changed over time, and the HGNC 
symbol differs from the name in the publication, gene names may be missed by the co-
occurrence script.  Moreover, different databases use different identifiers for the same 
gene (e.g. NCBI and Ensembl), and publication authors may use these identifiers 
interchangeably.  Therefore, it would be helpful to have a method to detect multiple gene 
names and different database identifiers. 
 Also,	  some	  of	  the	  abstracts	  have	  been	  published	  after	  the	  release	  of	  iRefIndex	  v.4.1;	   therefore,	   PPIs	   outlined	   in	   these	   abstracts	  would	   be	   identified	   as	   FPs	  when	  they	  are	  actually	  TPs.	  	  Rerunning	  the	  script	  with	  a	  new	  version	  of	  iRefIndex,	  as	  well	  as	   ensuring	   that	   the	   publications	   examined	   by	   the	   script	   are	   not	   newer	   than	   the	  latest	  version	  of	  the	  benchmark	  may	  help	  identify	  more	  TPs	  and	  fewer	  FPs.	  	  	  
The pipeline needs to be expanded to other domains, besides WW-­‐containing	  proteins,	  and	  updated	  with	  the	  latest	  version	  of	  iRefIndex	  as	  a	  benchmark.  Abstract 
selection needs to reflect the dates of the publications to correlate with the benchmark 
and not include abstracts published after the benchmark release. 	   The	   controlled	   vocabulary	   needs	   to	   be	   expanded	   and	   adapted	   to	   more	  natural	   language	  processing	  (e.g.	   ‘does	  not	   interact’,	   ‘but	  not’	  or	   ‘except’)	  [Fig.	   5.1,	  NLP	   terms	   highlighted	   in	   red].	   	   Furthermore,	   it	   would	   be	   helpful	   to	   include	   the	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distance	  between	  terms	  and	  assign	  weights	  to	  interactions	  based	  on	  how	  far	  protein	  names	  are	  from	  each	  other	  in	  the	  abstract.	  
Figure 5.1: An abstract describing the interaction of Smurf2 and Smad1 proteins in 
vivo (Lin et al. 2000) 
 
Smads are important intracellular signaling effectors for transforming growth factor-beta (TGF-
beta) and related factors. Proper TGF-beta signaling requires precise control of Smad functions. 
In this study, we have identified a novel HECT class ubiquitin E3 ligase, designated Smurf2, that 
negatively regulates Smad2 signaling. In both yeast two-hybrid and in vitro binding assays, we 
found that Smurf2 could interact with receptor-activated Smads (R-Smads), including Smad1, 
Smad2, and Smad3 but not Smad4. Ectopic expression of Smurf2 was sufficient to reduce the 
steady-state levels of Smad1 and Smad2 but not Smad3 or Smad4. Significantly, Smurf2 
displayed preference to Smad2 as its target for degradation. Furthermore, Smurf2 exhibited 
higher binding affinity to activated Smad2 upon TGF-beta stimulation. The ability of Smurf2 to 
promote Smad2 destruction required the HECT catalytic activity of Smurf2 and depended on the 
proteasome-dependent pathway. Consistent with these results, Smurf2 potently reduced the 
transcriptional activity of Smad2. These data suggest that a ubiquitin/proteasome-dependent 
mechanism is important for proper regulation of TGF-beta signaling. 
 
 
J Biol Chem. 2000	  Nov	  24;275(47):36818-­‐22.	  Smurf2	  is	  a	  ubiquitin	  E3	  ligase	  mediating	  proteasome-­‐dependent	  degradation	  of	  Smad2	  in transforming growth factor-beta signaling.	  	  
Lin X1, Liang M, Feng XH.	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Appendix A – Database ER diagram  
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Appendix B – Ensembl repository search results, using the Biomart 
query engine:  
http://www.ensembl.org/biomart/martview/  
 
Search filters:  
 
Database: Ensembl genes 81 
Dataset: Homo Sapiens Genes (GRCh38.p3) 
Protein domain: IPR001202 (corresponds to WW domain InterPRO ID) 
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Appendix C – Ensembl repository search results for WW domain  
 
50 WW domain-containing proteins (ensembl_ww_sorted.txt) 
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        <PMID Version="1">24008736</PMID> 
            <ArticleTitle>WWOX suppresses autophagy for inducing 
apoptosis in methotrexate-treated human squamous cell 
carcinoma.</ArticleTitle> 
                <AbstractText>Squamous cell carcinoma (SCC) cells 
refractory to initial chemotherapy frequently develop disease 
relapse and distant metastasis. We show here that tumor 
suppressor WW domain-containing oxidoreductase (WWOX) (also named 
FOR or WOX1) regulates the susceptibility of SCC to methotrexate 
(MTX) in vitro and cure of SCC in MTX therapy. MTX increased WWOX 
expression, accompanied by caspase activation and apoptosis, in 
MTX-sensitive SCC cell lines and tumor biopsies. Suppression by a 
dominant-negative or small interfering RNA targeting WWOX blocked 
MTX-mediated cell death in sensitive SCC-15 cells that highly 
expressed WWOX. In stark contrast, SCC-9 cells expressed minimum 
amount of WWOX protein and resisted MTX-induced apoptosis. 
Transiently overexpressed WWOX sensitized SCC-9 cells to 
apoptosis by MTX. MTX significantly downregulated autophagy-
related Beclin-1, Atg12-Atg5 and LC3-II protein expression and 
autophagosome formation in the sensitive SCC-15, whereas 
autophagy remained robust in the resistant SCC-9. 
Mechanistically, WWOX physically interacted with mammalian target 
of rapamycin (mTOR), which potentiated MTX-increased 
phosphorylation of mTOR and its downstream substrate p70 S6 
kinase, along with dramatic downregulation of the aforementioned 
proteins in autophagy, in SCC-15. When WWOX was knocked down in 
SCC-15, MTX-induced mTOR signaling and autophagy inhibition were 
blocked. Thus, WWOX renders SCC cells susceptible to MTX-induced 
apoptosis by dampening autophagy, and the failure in inducing 
WWOX expression leads to chemotherapeutic drug 
resistance.</AbstractText> 
</PubmedArticle> 
</data>	   	  
	  	   76	  
Appendix E – A Python script to parse downloaded abstract search 
results in XML format and store in the database 
#!/usr/bin/python 
 




# RUNS ON LARISA-DEV 
db = MySQLdb.connect(host="localhost", user="root", 
passwd="password", db="binding_site") 
cursor = db.cursor() 
 
tree = ET.parse('pubmed_result.xml') 
root = tree.getroot() 
 
for child in root: 
    for c2 in child: 
        if c2.tag == 'PMID': 
            pmID = c2.text.strip() 
        elif c2.tag == 'ArticleTitle': 
            title = c2.text.strip() 
        elif c2.tag == 'AbstractText': 
            abstract = c2.text.strip()	  
 
cursor.execute("INSERT INTO abstracts(pmID, title, 
abstract) VALUES('" + pmID + "', '" + title.replace("'", 
"''") + "', '" + abstract.replace("'", "''") + "')") 	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Appendix F – iRefIndex PPI dataset, used as the benchmark set in PPI 
prediction script (ww_benchmark.tsv) 	  Sample:	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Appendix G – A Python script to detect co-occurrence between WW 







# RERUN W/O CV, PURE CO-OCCURRENCE 
# ABSTRACTS ARE FROM 2012 
# RUNS ON LARISA-DEV, DATABASE binding_site 
 
# EXCEPTIONS: NES, INS, NTS, TES, TRO, EFS - Deleted them from 





import shlex, subprocess 
 
# RUNS ON LARISA-DEV 
db = MySQLdb.connect(host="localhost", user="root", 
passwd="password", db="binding_site") 
cursor = db.cursor() 
 
# WW genes 
cursor.execute("SELECT * FROM ww_genes") 
results_ww = cursor.fetchall() 
 
ww_genes = [] 
 
for r_ww in results_ww: 
    ww_gene = r_ww[0] 
    ww_genes.append(ww_gene) 
 
wg_set = set(ww_genes) 
 
# ALL genes 
cursor.execute("SELECT * FROM genes") 
results_g = cursor.fetchall() 
 
genes = [] 
 
for r_g in results_g: 
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    gene = r_g[0] 
    genes.append(gene) 
 
cursor.execute("SELECT * FROM ww_abstracts_unique") 
abst_res = cursor.fetchall() 
 
abstrDict = {} 
 
for a_res in abst_res: 
    pm_ID = a_res[0] 
    abstr = a_res[1] 
    print pm_ID 
 
    abstrDict[pm_ID] = abstr 
 
s_genes = set(genes) 
 




for pmID in abstrDict.keys(): 
 
    if pmID != "": 
        abstract = abstrDict[pmID] 
        #print abstract 
 
        for ww_gene in wg_set: 
            #print 'WW gene: ' + ww_gene.lower() 
            #print abstract.lower() 
 
            combos = [] 
 
            # whole-word 
            combos.append(" " + ww_gene.lower() + " ") 
 
            # CANNOT use this, b/c gene 'INS' would return a 
match for 'proteins' or 'domains' and gene 'NTS' matches 
'variants' or 'elements', 'IDE' would match 'nucleotide' 
            #combos2.append(g.lower() + " ") 
 
            # and this would probably match 'insert' 
            #combos2.append(" " + g.lower()) 
 
            # Dashes 
 
            # And this matches REL to "-related"!! 
            #combos2.append("-" + g.lower()) 
 
            combos.append("-" + ww_gene.lower() + " ") 
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            for p in punctuation: 
                combos.append("-" + ww_gene.lower() + p) 
 
            combos.append(" " + ww_gene.lower() + "-") 
            combos.append("-" + ww_gene.lower() + "-") 
 
            # Brackets 
            combos.append("(" + ww_gene.lower() + ")") 
 
            # Slashes 
            combos.append("/" + ww_gene.lower()) 
            combos.append(ww_gene.lower() + "/") 
 
            for p in punctuation: 
                combos.append("/ " + ww_gene.lower() + p) 
 
            for p in punctuation: 
                combos.append(ww_gene.lower() + p) 
 
            s_comb = set(combos) 
            #print `s2_comb` 
 
            for s in s_comb: 
                if abstract.lower().find(s.lower()) >= 0: 
                    print ww_gene + " found in abstr " + pmID 
 
                    for g in s_genes: 
                        if g != ww_gene and len(g) >= 3: 
     
                            combos2 = [] 
 
                            # whole-word 
                            combos2.append(" " + g.lower() + " ") 
     
                            # CANNOT use this, b/c gene 'INS' 
would return a match for 'proteins' or 'domains' and gene 'NTS' 
matches 'variants' or 'elements', 'IDE' would match 'nucleotide' 
                            #combos2.append(g.lower() + " ") 
     
                            # and this would probably match 
'insert' 
                            #combos2.append(" " + g.lower()) 
     
                            # Dashes 
     
                            # And this matches REL to "-
related"!! 
                            #combos2.append("-" + g.lower()) 
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                            combos2.append("-" + g.lower() + " ") 
     
                            for p in punctuation: 
                                combos2.append("-" + g.lower() + 
p) 
     
                            combos2.append(" " + g.lower() + "-") 
                            combos2.append("-" + g.lower() + "-") 
     
                            # Brackets 
                            combos2.append("(" + g.lower() + ")") 
     
                            # Slashes 
                            combos2.append("/" + g.lower()) 
                            combos2.append(g.lower() + "/") 
     
                            for p in punctuation: 
                                combos2.append("/ " + g.lower() + 
p) 
     
                            for p in punctuation: 
                                combos2.append(g.lower() + p) 
     
                            s2_comb = set(combos2) 
    
                            for s2 in s2_comb: 
                                if 
abstract.lower().find(s2.lower()) >= 0: 
                                    print ww_gene + " and " + g + 
" were found in abstract " + pmID 
 
                                    # check reverse interaction!! 
                                    if g in wg_set: 
                                        cursor.execute("SELECT * 
FROM co_occ_rerun_new_abstr WHERE gene1=" + `g` + " AND gene2=" + 
`ww_gene` + " AND pmID=" + `pmID`) 
                                        result = 
cursor.fetchone() 
     
                                        if not result: 
                                            
cursor.execute("INSERT INTO co_occ_rerun_new_abstr(pmID, gene1, 
gene2) VALUES(" + `pmID` + ", " + `ww_gene` + ", " + `g` + ")") 
                                            break 
                                    else: 
                                        # still check if recorded 
                                        cursor.execute("SELECT * 
FROM co_occ_rerun_new_abstr WHERE gene2=" + `g` + " AND gene1=" + 
`ww_gene` + " AND pmID=" + `pmID`) 
                                        result = 
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cursor.fetchone() 
 
                                        if not result: 
                                            
cursor.execute("INSERT INTO co_occ_rerun_new_abstr(pmID, gene1, 
gene2) VALUES(" + `pmID` + ", " + `ww_gene` + ", " + `g` + ")") 
                                        break 
                    break	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Appendix H – A Python script to compare predictions to benchmark 






# RUNS ON LARISA-DEV 
db = MySQLdb.connect(host="localhost", user="root", 
passwd="password", db="binding_site") 
cursor = db.cursor() 
 
outfile = open('co_occ_rerun_verification.tsv', 'w') 
 
cursor.execute("SELECT * FROM ww_new_bm") 
results = cursor.fetchall() 
 
benchmark = [] 
 
for result in results: 
    gene1 = result[0] 
    gene2 = result[1] 
 
    tup1 = (gene1, gene2) 
 





cursor.execute("SELECT * FROM co_occ_rerun_new_abstr") 
results2 = cursor.fetchall() 
 
for result2 in results2: 
 
    pmID = result2[0].strip() 
 
    gene1 = result2[1].strip() 
    gene2 = result2[2].strip() 
 
    b_tup = (gene1, gene2) 
    b_tup_rev = (gene2, gene1) 
 
    outfile.write(pmID + '\t' + gene1.strip() + '\t' + 
gene2.strip() + '\t') 
 
    if b_tup not in benchmark and b_tup_rev not in benchmark: 
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        outfile.write("FP\n") 
 
    elif b_tup in benchmark or b_tup_rev in benchmark: 
        outfile.write("TP\n")	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from Bio import Entrez 
 
from EUtils import HistoryClient 
 
Entrez.email = 'molhovsky@gmail.com' 
 
# Oct. 2, 2012: Search ENTIRE human genome, WW-prots AND 
their interactors 
genes_file = open("approved_hgnc_symbol_biomart.txt", 'r') 
 
ww_prots = [] 
 
outfile = open("mesh_results.txt", 'w') 
 
url = "http://www.ncbi.nlm.nih.gov/mesh/" 
 
ret_max = 1000 
 
num_abstr = 1 
 
pmids = []  # list of Pubmed IDs 
pubmedDict = {} # dictionary: geneSymbol => [pmIDs] 
search_str = "" 
 
f_err1 = open("no_mesh_ids.txt", 'w') 
f_err2 = open("too_many_mesh_ids.txt", 'w') 
 
p_set = [] 
 
for line in genes_file.readlines(): 
 prot = line.strip() 
 p_set.append(prot) 
 
pSet = set(p_set) 
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non_human_mesh = open('non_human_mesh.txt', 'w') 
gen_err_file = open('mesh_err.txt', 'w') 
 
for prot in pSet: 
  try: 
  handle = Entrez.esearch(db="mesh", term='"' + prot + 
'"', rettype='text', retmax=ret_max) 
  record = Entrez.read(handle) 
  mesh_ids = record ["IdList"] 
 
  if len(mesh_ids) == 0: 
   f_err1.write("No Mesh IDs for " + prot + '\n') 
 
  elif len(mesh_ids) <= 5: 
   for uid in mesh_ids: 
    try: 
     #handle2 = 
urllib.urlopen("http://www.ncbi.nlm.nih.gov/mesh?term=" + uid + 
"[uid]") 
     handle2 = urllib.urlopen(url + uid) 
     record2 = handle2.read() 
 
     s1 = record2.find("[Supplementary 
Concept]") 
 
     i = s1 
     c = record2[i] 
 
     while c != ">": 
      i -= 1 
      c = record2[i] 
 
     mesh_term = record2[i+1:s1] 
 
     if mesh_term.lower().strip() == 
prot.lower().strip() + " protein, human": 
      outfile.write(prot + '\t' + 
mesh_term + '\n') 
 
     else: 
      non_human_mesh.write(prot + '\t' 
+ mesh_term + '\n') 
 
    except urllib2.URLError: 
     gen_err_file.write(prot + '\n') 
     Entrez.email = 'gingerbraid@yahoo.com' 
     continue 
  else: 
   f_err2.write("Too many IDs: " + prot + '\n') 
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 except RuntimeError: 
  gen_err_file.write(prot + '\n') 
  Entrez.email = 'olhovsky@lunenfeld.ca' 
  continue 
 
 except IOError: 
  gen_err_file.write(prot + '\n') 
  Entrez.email = 'olhovsky@lunenfeld.ca' 
  continue 
 
 except urllib2.URLError: 
  gen_err_file.write(prot + '\n') 
  Entrez.email = 'olhovsky@lunenfeld.ca' 
  continue 
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Appendix J – Python script for retrieving all MeSH abstracts in 








from Bio import Entrez 
 
from EUtils import HistoryClient 
from Bio import Entrez 
 
Entrez.email = 'molhovsky@gmail.com' 
 
ww_prots_file = open("ensembl_ww_sorted.txt", 'r') # all WW-
containing proteins (51 total) 
ww_prots = [] 
 
outfile = open("abstracts_EUtils.txt", 'w') 
 
ret_max = 1000 
 
num_abstr = 1 
 
err_file = open('over_1000_abstracts.txt', 'w') 
 
mesh_dict = {} # prot, [MeSH Terms] query string 
 
mesh_outfile = open("mesh_terms.txt", 'w') 
 
for line in ww_prots_file.readlines(): 
 prot = line.strip() 
 
 mesh_terms = "http://www.ncbi.nlm.nih.gov/pubmed?term=" 
 
 handle = Entrez.esearch(db="pubmed", term=prot, 
retmax=ret_max) 
 
 record = Entrez.read(handle) 
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 max_ret = int(record["Count"]) 
 
 if max_ret > ret_max: 
  print "More than 1000 entries for " + prot 
 
  err_file.write(prot + '\t' + `max_ret` + '\n') 
  continue 
 
 for pmID in record["IdList"]: 
 
  h2 = Entrez.efetch(db="pubmed", id=pmID, 
rettype="abstract", retmode="xml") 
 
  for line in h2.readlines(): 
   ind1 = line.find("<AbstractText>") 
   ind2 = line.find("</AbstractText>") 
 
   if ind1 > 0 and ind2 > 0 and ind2 > ind1: 
    outfile.write(`num_abstr` + ". " + 
line[ind1+len("<AbstractText>"):ind2] + "\n\n") 
    num_abstr += 1 
 
   # Find MeSH terms: 
   if line.strip().find('<DescriptorName') == 0: 
  
    m_ind1 = line.strip().find(">") 
    m_ind2 = line.strip().find('</DescriptorName>') 
 
    if m_ind1 > 0 and m_ind2 > 0 and m_ind2 > 
m_ind1: 
     mesh_descr = line.strip()[m_ind1+1:m_ind2] 
 
     if mesh_terms == 
"http://www.ncbi.nlm.nih.gov/pubmed?term=": 
      mesh_terms = '"' + mesh_descr + 
'"[MeSH Terms]' 
     else: 
      mesh_terms += " AND " + '"' + 
mesh_descr + '"[MeSH Terms]' 
 
  mesh_dict[prot] = mesh_terms 
 
  mesh_outfile.write('\n' + prot + '\n' + mesh_terms + 
'\n\n') 
 
